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To examine the role of the calcium/calmodulin-dependent
phosphatase calcineurin in regulation of renin release, we
assayed exocytosis using whole-cell patch clamp of single
juxtaglomerular cells in culture. The calcineurin inhibitor,
cyclosporine A (CsA), significantly increased juxtaglomerular
cell membrane capacitance, an index of cell surface area and
an established measure of exocytosis in single-cell assays.
This effect was mimicked by intracellular delivery of a
calcineurin inhibitory peptide, the calcium chelator ethylene
glycol tetraacetic acid (EGTA), or the calmodulin inhibitor
W-13. Simultaneous exposure to EGTA and CsA had no
additive effect. The protein kinase A (PKA) blocker RpcAMPs
had no effect on the CsA-induced increase in membrane
capacitance. Intra- and extracellular application of tacrolimus
did not alter membrane capacitance. A calmodulin
antagonist (calmidazolium) and CsA, but not tacrolimus,
significantly stimulated renin release from cultured
juxtaglomerular cells. Juxtaglomerular cells expressed the
calcineurin isoforms A-b and A-c but not A-a. Plasma renin
concentrations (PRCs) were not different in wild-type,
calcineurin A-a, or A-b knockout mice but increased after CsA
treatment of the A-a knockout, while renin mRNA was
suppressed. We conclude that calcineurin and calcium/
calmodulin suppress exocytosis of renin from
juxtaglomerular cells independent of PKA.
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Renin is stored and released by juxtaglomerular granular (JG)
cells in the distal part of the afferent renal arterioles. The
activity of the circulating renin–angiotensin–aldosterone
system is determined by the secretion rate of active renin
from JG cells. In most secretory cells, a rise in the intracellular
concentration of calcium ([Ca2þ ]i) initiates or maintains
secretory activity, but a rise in [Ca2þ ]i is associated with
inhibition of renin release: calcium channel blockers
stimulate renin release,1 depolarization activates calcium
channels and inhibits renin release in single JG cells,2 cell-
permeable calcium chelators increase renin release,3 libera-
tors of calcium from intracellular stores inhibit renin release,4
and calcium-mobilizing hormones suppress renin secretion.5
Calcium inhibits adenylate cyclase, isoforms 5 and 6, in JG
cells, and thereby impairs the ability of the cells to increase
cyclic adenosine monophosphate (cAMP) and renin secre-
tion.3,6 A second relevant target for calcium in JG cells is the
calcium-dependent protein calmodulin, as inhibitors of
calmodulin increase renin release from in vitro prepara-
tions.7–9 Because adenylate cyclases 5 and 6 are not sensitive
to calmodulin,10 an additional calcium-regulated, inhibitory,
renin secretory pathway is likely to exist. This notion is
supported by the observation that activation of voltage-gated
calcium channels by depolarization prevents cAMP-mediated
exocytosis of renin in single JG cells, which indicates that
calcium may inhibit renin secretion independently of
formation of cAMP.2 To explain this effect, the calcium/
calmodulin-stimulated protein phosphatase calcineurin ap-
pears relevant. Calcineurin inhibitor immunosuppressants
increase plasma renin concentration (PRC)11–14 and cyclos-
porine A (CsA) stimulates renin secretion from JG cell
cultures in a cAMP-independent manner.15 Calcineurin is a
heteromultimeric protein, and the catalytic A subunit exists
in three different isoforms encoded by distinct genes.16,17 In
this study we hypothesized that (1) catalytic calcineurin
subunits are expressed in renin-secreting JG cells, (2)
calcineurin activity suppresses exocytosis of renin, and (3)
calcium inhibits exocytosis of renin through calmodulin-
dependent calcineurin activity. These hypotheses were
analyzed in single JG cells with the whole-cell patch-clamp
approach. This technique enables real-time recordings of
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exocytosis independent of systemic factors and it has been
extensively validated on single JG cells.18,19 Electrophysio-
logical data were corroborated by studies of renin release
from primary cultures of renal cortical cells enriched in
JG cells. PRC was measured in wild-type mice and mice
with disruption of calcineurin A-a and A-b isoforms with
and without CsA treatment.
RESULTS
The whole-cell recording was obtained in single JG cells
isolated from 32 preparations. JG cells showed outward
current rectification at positive membrane potentials
and very limited net currents between 30 and 0 mV.18,19
The JG cells had an average membrane capacitance
(Cm) value of 2.00±0.15 pF (n¼ 33). Mean Cm values
determined at t¼ 0 in each experimental series were not
significantly different. Under control conditions, Cm was
stable, and the current–voltage relationship was not affected
by the whole-cell mode within the time of recording
(10 min).
Effect of calcineurin antagonists on juxtaglomerular cell
membrane capacitance (Cm) and renin secretion
Cyclosporine A (5mmol/l) increased significantly JG-cell Cm
(Po0.05, Figure 1a and e). Whole-cell currents did not
change (Figure 1a). Tacrolimus (0.1 mmol/l) added in the
bath had no effect on Cm (Figure 1b and e). When added
directly to the JG-cell cytoplasm, tacrolimus (0.1 mmol/l) did
not change Cm (Figure 1c and e, n¼ 5). A calcineurin-
inhibitory peptide evoked a significant increase in Cm when
dialyzed into single JG cells (Figure 1d and e). Tacrolimus
and calcineurin inhibitory peptide had no effect on whole-
cell currents (data not shown). CsA significantly stimulated
renin release from JG cells (Po0.01, Figure 2a). Tacrolimus
had no effect on renin release from JG cells (Figure 2b). A
combined application of forskolin and CsA significantly
augmented renin secretion from JG cells compared with CsA
and forskolin alone (Figure 2c). Forskolin stimulated renin
release significantly compared with control in all series
(Figure 2a–c, Po0.01).
Expression of catalytic calcineurin A subunit isoforms and
calcineurin inhibitor binding proteins
Calcineurin A-b (CnA-b) and CnA-g, but not CnA-a, were
detected in preglomerular rat microvessels (Figure 3a). The
microvessels and renin-producing As4.1 cells expressed
binding proteins for CsA and tacrolimus (Figure 3b). In
patch pipette-sampled native JG cells, CnA-a was at the limit
of detection, whereas CnA-b and CnA-g were readily
amplified (Figure 3c). As4.1 cells expressed CnA-b and
CnA-g but not CnA-a (Figure 3d). CnA-a and CnA-g
primers did not cross-amplify the other calcineurin isoform
(Figure 3e and f). Amplified products were 100% homo-
logous to GenBank sequences. Amplification was achieved
only in the presence of reverse transcriptase and cDNA
(Figure 3).
Effect of protein kinase A (PKA) inhibitor and a calcium
chelator on the capacitance-response to CsA in
juxtaglomerular cells
The PKA inhibitor, RpcAMPs (5 mmol/l), did not alter the
CsA-mediated increase in Cm (Figure 4a). When [Ca
2þ ]i was
lowered by dialysis of single JG cells with ethylene glycol
tetraacetic acid (EGTA; 0.1 mmol/l), Cm increased promptly
(Figure 4b). When EGTA and CsA were added simulta-
neously to single JG cells, there was no further augmentation
of Cm by the combination, compared with CsA or EGTA
alone (Figure 4c). Whole-cell currents did not change by any
of these maneuvers (data not shown).
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Figure 1 | Effect of calcineurin inhibitors on JG cell membrane
capacitance (Cm) in single rat JG cells. Schematic cell models in
(a–d) show the experimental approaches with intra- and
extracellular application of inhibitors. (a) Left: The trace from a
single JG cell shows the effect of superfusion with cyclosporine A
(CsA; 5 mmol/l) on Cm. Right: The average current–voltage (I-V)
relationship was measured immediately after the whole-cell
configuration was obtained in single JG cells (filled circles). The
measurement was repeated 10min after application of CsA (filled
squares). (b, c) The Cm traces from single JG cells show the effect
of (b) superfusion and (c) intracellular dialysis with tacrolimus
(0.1mmol/l) on Cm. (d) The Cm recording from a single JG cell
shows the effect of intracellular dialysis with calcineurin inhibitory
peptide (CIP, 100mmol/l). (e) Average changes of Cm in response
to CsA, extra- and intracellular tacrolimus, and CIP±s.e. *Po0.05
at t¼ 0 vs t¼ 10min (n¼ 4–6).
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Effect of calmodulin antagonist on JG cell membrane
capacitance and renin secretion
Intracellular dialysis with the calmodulin antagonist W-13
(100 mmol/l) increased Cm significantly (Figure 5a). The
stimulatory effect of W-13 was not modified by concomitant
dialysis of single JG cells with the PKA inhibitor RpcAMPs
(Figure 5b). The cell-permeable calmodulin antagonist
calmidazolium stimulated renin release significantly from
primary cultures of JG cells. (Figure 5c).
Effect of cyclosporine A (CsA) on plasma renin concentration
(PRC) and renin mRNA level in wild-type mice and mice with
targeted disruption of calcineurin isoforms
Basal PRC was not significantly different in CnA-b/ and
CnA-a/ mice compared with wild-type littermates
(Figure 6a). Treatment with cyclosporine for 4 days did not
alter PRC significantly in wild-type mice (Po0.07, Figure 6a)
and in CnA-b/ mice (Po0.2), but led to a significant
increase in CnA-a/ mice (Po0.01, Figure 6a). Renin
mRNA level (Figure 6b) was not significantly different
between wild-type and CnA-a/ mice. CsA treatment
significantly suppressed renin mRNA level in kidneys from
wild-type mice and CnA-a/ mice (Figure 6b). In renin-
expressing As4.1 cells, CsA suppressed renin mRNA level
after a 20-h incubation, whereas forskolin significantly
increased renin mRNA abundance (Figure 6c).
DISCUSSION
In this study, individual JG cells were used for patch clamp
when they showed the characteristic current–voltage rela-
tion.2,18,19 An increase in Cm indicates net addition of
membrane to the cell surface and is a well-established
measure of exocytosis at the single-cell level.20 Chelation of
intracellular calcium and inhibitors of calmodulin and the
serine/threonine phosphatase calcineurin all stimulated
exocytosis of renin. Exocytosis of renin subsequent to
exposure to CsA and calmodulin antagonist was not
dependent on cAMP/PKA and was not accompanied by
changes in membrane currents, which are stimulated
consistently by cAMP.18 The macrolide calcineurin inhibitor
tacrolimus had no effect on Cm and renin secretion.
Increases in Cm of B10%, as observed in this study,
corresponds to release of app.10 granules from mouse JG
cells18 and the data are compatible with the notion that
calcineurin is a target protein for calcium/calmodulin in a
cAMP-independent pathway that suppresses exocytosis of
renin granules (Figure 7). This is consistent with previous
data showing that calmodulin antagonists and calcineurin
inhibitors do not alter cAMP in JG cells.7,15 The present data
show directly at the single-cell level that intracellular calcium
constitutes a ‘brake’ on renin exocytosis. Calcineurin is calcium-
calmodulin dependent, but multiple signaling pathways are
likely altered through chelation of calcium. Thus, chelation of
intracellular calcium by cell-permeable 1,2-bis(o-aminophenoxy)
ethane-N,N,N0,N0-tetraacetic acid raises cAMP in JG cell
cultures, probably through calmodulin-independent stimula-
tion of adenylate cyclases 5 and 6, and a similar response
could contribute to the observed rise of Cm in single JG cells
after EGTA.3 The in vitro data imply that calcineurin phos-
phatase is constitutively active to suppress renin exocytosis.
The prolonged treatment of wild-type mice with CsA in vivo
tended to increase PRC, which is similar to data from rats in
which a 7-day treatment protocol resulted in PRC changes at
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Figure 2 |Renin release experiments. (a) Renin release from
primary cultures of renal cortical cells enriched in JG cells in
response to cyclosporine A in mol/l (CsA, *Po0.01, n¼ 16 from
four different preparations, at 20-h incubation). The figure shows
renin release as the percentage of total renin content. Forskolin
(F) served as a positive control. *Po0.01 compared with control.
(b) Renin release from primary cultures of renal cortical cells
enriched in JG cells in response to tacrolimus in mol/l (Tac).
The figure shows renin release as the percentage of total renin
content. Forskolin (F) served as a positive control. *Po0.01, n¼ 12
from three different preparations. (c) Renin release from primary
cultures of renal cortical cells enriched in JG cells in response
to forskolin (F, 10–5mol/l), CsA (C, 10–4mol/l), and combined
forskolin and cyclosporin A (FþC). Renin release is shown
as the percentage of total renin content. *Po0.05 compared
with all other conditions; n¼ 11 from three different preparations.
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the limit of significance.21 This difference between in vitro and
in vivo sensitivity to cyclosporine is likely caused by the different
time of intervention and the highly redundant regulation of
renin secretion at the systemic level. It has been discussed
whether the stimulatory effect of CsA on renin release in vivo
is due to a direct effect on JG cells or it is secondary to
hemodynamic changes induced by CsA.22,23 These data show
that CsA directly and acutely stimulates exocytosis of renin,
consistent with observations in JG cell cultures by Kurtz et al.15
The concentrations of CsA and tacrolimus applied to the JG
cells are clinically relevant as plasma concentrations observed
at nadir and peak in patients typically are in the micromolar
range (cyclosporin) and nanomolar range (tacrolimus).24 The
main intracellular target of both CsA and tacrolimus is calci-
neurin, but the two drugs showed differential effects on renin
release and Cm changes. At the systemic level, differential effects
on cardiovascular parameters have been reported. Klein et al.25
showed increased blood pressure, increased renal vascular
resistance, and decreased renal blood flow in response to CsA
in healthy adult volunteers, whereas tacrolimus induced no
such changes. Similar findings have been obtained in rats.22,23
The lack of effect of tacrolimus was not caused by impaired
cellular uptake or absence of binding protein.26,27 Differential
effects of blockers on distinct calcineurin isoforms could be
involved. Thus, three separate genes encode the catalytic
subunit of calcineurin, CnA-a, CnA-b, and CnA-g. CnA-a is
developmentally downregulated in rodent kidney.28 In
agreement, CnA-a was at the limit of detection in
preglomerular vasculature and JG cells, and PRC increased
significantly by CsA in CnA-a/ mice. This indicates a
minor role of this isoform in the control of renin secretion
and mRNA. CnA-b and CnA-g were expressed in the renal
vasculature and in single JG cells. CnA-b is of major
importance for T-lymphocyte function29 and has significant
cardiovascular effects,30 but its deletion did not alter basal
PRC. This could be caused by redundant, compensatory
effect of intact CnA-g. CnA-g has previously only been
described in testis and brain tissue17 and targeted deletion has
not yet been achieved. If there is redundancy between CnA-g
and CnA-b in the control of renin, a preferential effect of
118
234
194
234
194
234
118
194
194
234 Cyclophilin
FKBP12
Actin
234
194
234
194
118
194
234
194
118
194
234
194
234
194
118
194
234
194
118
194
194α
β
γ
α
β
γ
α
β
γ
α
γ
α
γ
234
Actin 194
194
Cerebru
m
–
cD
N
A
M
W
–D
N
A
–RT
Kidney
Cerebru
m
CnA-α
 pl
–RT
Kidney
CnA-γ
 pl
M
W
M
W
M
W
1 cell
0.1 cell
0.01 cell
–RT
–
cD
N
A
Kidney
M
W
M
W
–RT
PG PG PG –cD
N
A
Kidney
As4.1
M
W
–RT
Cerebru
m
H
2 O
Kidney
As4.1
As4.1
M
W
PG PG PG –RT
–
cD
N
A
Kidney
Figure 3 | Expression of catalytic calcineurin isoforms and calcineurin inhibitor immunosuppressant (CNI) binding proteins in
preglomerular microvessels and single JG cells using PCR. In all experiments, negative controls were omission of reverse transcriptase
(RT) and cDNA (cDNA) and molecular size marker (MW) was fX174DNA/Hae III fragments. (a) Amplification of cDNA from microdissected
preglomerular (PG, n¼ 3) microvessels for calcineurin A (CnA)-a, CnA-b, and CnA-g. CnA-a was not detected. (b) Amplification of cDNA
from PG microvessels (n¼ 3) for cyclophilin and FKBP12. Cyclophilin and FKBP12 were readily amplified with the expected molecular size
(186 and 134 bp, respectively) from microvessels and renin-producing As4.1 cells. (c) Amplification of serially diluted cDNA from single,
sampled JG cells for CnA isoforms. CnA-b and CnA-g were readily detected. (d) Amplification of cDNA from two preparations of As4.1 cells
for CnA isoforms. CnA-b and CnA-g were readily detected. (e) Amplification of CnA-a and CnA-g with plasmid template (pl) carrying the
full sequence of murine CnA-a. Only CnA-a was readily amplified. Expected molecular size: 187þ 15 bp, þ 15 refers to the addition of
restriction sites. (f) Amplification of CnA-a and CnA-g with plasmid template (pl) carrying the full sequence of calcineurin A-g. Only CnA-g
was readily amplified. Expected molecular size: 117þ 15 bp.
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tacrolimus on one isoform could be a relevant explanation
for the lack of effect on renin secretion by tacrolimus. These
data show suppression of renin mRNA in vivo after treatment
with CsA for 4 days and the effect was also found in vitro,
which implies a direct effect that potentially could be
mediated by the nuclear factor of activated T-cells transcrip-
tion factors, which are expressed in vessels. We show a direct
and differential effect of clinically used calcineurin inhibitors
to stimulate exocytosis of renin from single JG cells in a
cAMP/PKA-independent manner. Chelation of intracellular
calcium and inhibition of calmodulin mimicked the effect of
calcineurin inhibition at the JG-cell level. CnA-b and CnA-g
are likely targets for calcium/calmodulin in a pathway leading
to suppression of renin exocytosis. Future studies should
explore and identify molecular substrate targets that are
dephosphorylated by calcineurin in JG cells.
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Figure 4 | Schematic cell models showing the experimental
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application of drugs. (a) Left: The Cm trace from a single JG cell
shows the effect of combined cyclosporine A (CsA; 5 mmol/l) and
dialysis of the cell with the protein kinase A (PKA) inhibitor
RpcAMPs (5 mmol/l). Right: average changes of Cm in response to
CsA and RpcAMPs. *Po0.05 at t¼ 0 vs t¼ 10min (n¼ 4). (b) Left:
A Cm trace obtained in a single JG cell shows the effect of
intracellular dialysis with ethylene glycol tetraacetic acid (EGTA;
0.1mmol/l). Right: average changes of Cm in response to EGTA.
*Po0.05 at t¼ 0 vs t¼ 10min (n¼ 4). (c) Left: The Cm trace from a
single JG cell shows the effect of CsA (5 mmol/l) and concomitant
dialysis of the cell with EGTA (0.1mmol/l). Right: average changes
of Cm in response to CsA and EGTA. *Po0.05 at t¼ 0 vs t¼ 10min
(n¼ 5).
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Figure 5 | Schematic cell models showing the experimental
approach with intracellular application of inhibitors through
the patch pipette. (a) Left: The Cm trace from a single JG cell
shows the effect of intracellular application of the calmodulin
inhibitor W-13 (100 mmol/l). Right: average changes in Cm in
response to W-13. *Po0.05 at t¼ 0 vs t¼ 10min (n¼ 4). (b) Left:
an original Cm trace from a single JG cell shows the effect of
simultaneous intracellular application of the calmodulin inhibitor
W-13 (100 mmol/l) and the protein kinase A (PKA) blocker
RpcAMPs (5 mmol/l). Right: average changes in Cm in response to
W-13 and RpcAMPs. *Po0.05 at t¼ 0 vs t¼ 10min (n¼ 4).
(c) Renin release from renal cortical cells enriched in JG cells in
response to a cell-permeable calmodulin inhibitor, calmidazolium
(Cal, n¼ 16 from four different preparations, *Po0.01). Forskolin
(F) served as positive control, *Po0.01.
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MATERIALS AND METHODS
In vivo experiments
All procedures conformed to the Danish national guidelines for the
care and handling of animals and the published guidelines from the
National Institutes of Health. Male Sprague–Dawley rats (60–80 g)
were housed at University of Southern Denmark, on a 12:12 h
light:dark cycle and had free access to standard pathogen-free rat
chow (Altromin-1310, Lage, Germany; Naþ 2 g/kg and Cl 5 g/kg)
and tap water. CnA-a/ and CnA-b/ mice were bred in the
animal facility at the Atlanta VA Medical Center following the
guidelines of the institution animal care and use committee.
Genotyping was performed as previously described.31 Wild-type
and CnA-a/ and CnA-b/ mice were treated with cyclosporine
20 mg/kg per day by intraperitoneal injection once daily for 4 days.
Mice were anesthetized with isoflurane and blood was sampled by
cardiac puncture. Kidneys were rapidly frozen in liquid nitrogen.
Isolation of juxtaglomerular cells
JG cells were isolated from rat renal cortex as described.19 A total of
40 rats were used. For patch clamp, cells were transferred to cover
slips in RPMI-1640 medium. A specific condition was tested on not
more than one cell from one preparation, and hence, for example,
n¼ 5 means recordings from five single cells from five different
animals. Renin secretion studies were performed as described.18,19
As4.1 cells were grown according to the American Type Culture
Collection instructions. As4.1 cell medium was replaced by
Dulbecco’s modied Eagle’s medium containing 2% fetal calf serum
at 24 h before experiments.
Patch-clamp experiments
The patch-clamp experiments were performed as described18,19 with
internal solution (in mmol/l): K-glutamate 135; NaCl 10; KCl 10;
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MgCl2 1; 4,(2-hydroxyethyl)-1-piperazine ethane sulphonic acid-
NaOH 10; magnesium-adenosine triphosphate 0.5; Na2-guanosine
triphosphate 0.3; osmolality was 303 mOsm/kg; pH 7.07 with or
without RpcAMPs (5 mmol/l). External solution was 4,(2-hydroxy-
ethyl)-1-piperazine ethane sulphonic acid-NaOH 10; NaCl 140;
KCl 2.8; MgCl2 1; CaCl2 2; glucose 11; sucrose 10; osmolality was
approximately 300 mOsm/kg (range 296–314 mOsm/kg); pH 7.25
with or without agonists/antagonists.
Reverse transcriptase-PCR analyses
Reverse transcriptase-PCR analysis of single JG cells and preglo-
merular vessels was as described.19 Primer sequences: CnA-a: sense
50-CAA-GAT-CCG-AGC-AAT-AGG-30 antisense 50-TCC-TTT-GAT-
GGC-TTC-ATC-30; CnA-b: sense 50-GGA-TGG-ATT-AGC-ATG-GTC-30
antisense 50-TAG-AAA-TAG-TTT-ATG-CAT-30; CnA-g: sense 50-CTG-
CTC-CTA-CTT-CTT-CAG-30 antisense 50-GAA-AGC-CAG-TTG-CTT-
GGT-30; Cyclophilin: sense 50-AAG-CCA-TGG-AGC-GTT-TTG-30
antisense 50-CTT-CAG-TGA-GAG-CAG-AGA-30; FKBP12: sense
50-TTG-ACT-CCT-CTC-GGG-ACA-30 antisense 50-CAT-AGT-CTG-
GGG-AGA-TTA-30. Actin primers were as described.19 Amplification
products were sequenced using the MWG sequencing service (Ebersberg,
Germany). For quantitative PCR, RNA was isolated from kidney tissue
using a kit (Qiagen, Copenhagen, Denmark) and cDNA was prepared as
previously described.32 Human brain RNA (20mg) was purchased from
Ambion (Applied Biosystems, Naerum, Denmark). An iQ-Thermocycler
(Bio-Rad, Copenhagen, Denmark) was used as described.32 Renin
primers: sense 50-GCT-ATG-TGA-AGA-AGG-CTG-30 and antisense
50-TTC-TCT-TCT-CCT-TGG-CTC-30. Renin concentration was deter-
mined as previously described.32,33
Agents
4,(2-hydroxyethyl)-1-piperazine ethane sulphonic acid (HEPES);
Tris-HCl; glucose, sucrose, insulin, penicillin, streptomycin, K-
glutamate, magnesium-adenosine triphosphate, forskolin, dithio-
threitol, trypsin, EGTA, CsA, tacrolimus, calmidazolium chloride,
and calcineurin-inhibitory peptide were from Sigma Chemical
(St Louis, MO, USA). RPMI 1640 and fetal calf serum were from
GIBCO Life Technologies (Invitrogen, Taastrup, Denmark). Col-
lagenase A, Na2-GTP, and cAMP were from Roche (Hvidovre,
Denmark). RpcAMPs were from Biomol (Plymouth Meeting, PA,
USA) and W-13 was from VWR (Bie & Berntsen, Herlev, Denmark).
Stock solutions of ligands were made in ethanol or dimethyl
sulfoxide and kept at 20 1C.
Statistics
The effect of a perturbation on Cm was determined as the difference
between Cm at t¼ 0 min and t¼ 10 min (DCm) and the null hypothesis
was that DCm¼ 0. This was tested using paired Student’s t-test. There
were no differences in mean Cm at t¼ 0 between the eight experimental
series in the study and data are presented as mean DCm±s.e. in
percentage of Cm at t¼ 0. Unpaired Student’s t-test was used to compare
means of two groups. Analysis of variance was used to determine
whether there was statistical significance among several groups of data
in renin secretion data. Dunnett’s test was performed post hoc to test
for significant differences between experimental groups and control
group. A Po0.05 was considered statistically significant. Calculations
were performed using GraphPadPrism software (La Jolla, CA, USA).
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